RESUMEN
For many decades and until recently, medical approach to dermatologic diseases has been based on the physician's ability to recognize and treat symptoms. Nowadays, advances in the understanding of the biology of diseases and in technologies for intervening against them have allowed physicians to diagnose and treat underlying disease processes rather than simply addressing the symptoms. This means that rather than addressing 'the disease in humans', physicians can now address the particular pathologic (biologic, molecular) disturbance as it presents in the individual patient, i.e., physicians now can practice something much closer to 'personalized medicine', leading to greater benefits for the patients and the health of society in general. The deeper understanding of ultraviolet radiation, the importance of photoprotection and increased knowledge about signalling pathways of melanoma and carcinoma have led to more complete care for the dermatologic patient. The current popularity for excessive exposure to the sun, without adequate application of the appropriate photoprotection remedies, is the origin of melanoma, but also for the weakening of the structure and functions of the skin. Indeed, fragility of the skin can affect humans around the world. In the senior population, this skin fragility is accompanied by pruritus, whereas atopic dermatitis is an inflammatory disease with highest prevalence in children and adolescents. Acne, the number one reason for dermatologic consultations worldwide, increases its prevalence in adolescents and in females. Senescent alopecia affects humans after menopause and andropause. The articles in this publication present an overview of the current advanced understanding of the diagnosis and therapeutic approaches in 6 fields of dermatology - dermatopaediatry and gerontodermatology, oncodermatology, hair loss, atopic dermatitis, photoprotection and acne - and thereby serve as a useful compendium of updated information and references for all healthcare professionals who see patients with presentations of the symptoms of these diseases.
Asunto(s)
Acné Vulgar/tratamiento farmacológico , Alopecia/terapia , Dermatitis Atópica/tratamiento farmacológico , Dermatología/tendencias , Neoplasias Cutáneas/tratamiento farmacológico , Protectores Solares/química , Rayos Ultravioleta/efectos adversos , Acné Vulgar/complicaciones , Cicatriz/etiología , Cicatriz/terapia , Dermatitis Atópica/fisiopatología , Humanos , Inmunoterapia , Cumplimiento de la Medicación , Terapia Molecular Dirigida , Medicina de Precisión , Envejecimiento de la Piel , Neoplasias Cutáneas/terapia , Protectores Solares/efectos adversosRESUMEN
The proportion of adults over 60 years of age is rapidly increasing and is estimated to reach approximately one-sixth of the global population by 2030. An ageing population is a real challenge for healthcare resources, including dermatologists and geriatricians, as age-related changes in skin integrity and barrier function make older adults more susceptible to developing skin pathologies such as pruritus, dermatitis and infections. Fragile skin arises from several interlinked causes, including age-related changes in skin barrier integrity, previous and current lifestyle choices, skin pathologies and medical interventions. Dermo-cosmetics can play a key role in enhancing skin care regimens and preventing pathologies in this age group. In vitro studies, clinical, and in-daily clinical practice studies of dermo-cosmetics have shown them to be effective in many skin conditions in older adults, like xerosis and pruritus. Incontinence-associated dermatitis (IAD), a common condition arising from contact with irritants such as urine and faeces which can significantly impact the quality of life of sufferers, can also be improved with a barrier cream in incontinent patients aged 70 years and older. This supplement focuses on the increased fragility of older skin, the development of common skin pathologies and the efficacy and tolerance of dermo-cosmetic products in older adults.
Asunto(s)
Epidermis/patología , Epidermis/fisiopatología , Enfermedades de la Piel/epidemiología , Factores de Edad , Anciano , Humanos , Persona de Mediana Edad , Cuidados de la Piel , Fenómenos Fisiológicos de la PielRESUMEN
The panoply of products used by hair care professionals to wash, dye, shape and beautify hair is not entirely free from adverse events. Such effects consist mainly of irritation dermatitis and allergic contact eczema affecting the scalp, as well as the back and front of the neck, the forehead and periorbital areas, and the cheeks. The most frequently cited allergens include paraphenylenediamine (PPD) in hair dyes, glycerol monothioglycolate (GMTG) in acid perm lotions, and ammonium persulphate in hair lighteners (the latter substance being responsible primarily for contact urticaria). However, care should also be paid to other allergens such as cocamidopropyl betaine among surfactants, as well as certain components in hair formulations such as preservatives and fragrances (as well as minoxidil, frequently used by patients).
Asunto(s)
Dermatitis Alérgica por Contacto/etiología , Dermatitis Irritante/etiología , Preparaciones para el Cabello/efectos adversos , Dermatitis Alérgica por Contacto/patología , Dermatitis Irritante/patología , Humanos , Minoxidil/efectos adversosAsunto(s)
Arteritis/inducido químicamente , Cannabis/efectos adversos , Fumar Marihuana/efectos adversos , Enfermedades de la Boca/inducido químicamente , Enfermedades de la Piel/inducido químicamente , Agricultura , Arteritis/patología , Cannabinoides/efectos adversos , Humanos , Enfermedades de la Boca/patología , Enfermedades Profesionales/inducido químicamente , Enfermedades Profesionales/patología , Enfermedades de la Piel/patologíaRESUMEN
BACKGROUND: Although acne vulgaris is a common skin disorder, limited epidemiological data exist specifically for European populations. OBJECTIVE: To determine the prevalence of self-reported acne among young people in Europe and evaluate the effect of lifestyle on acne. METHODS: We conducted a cross-sectional population-based online survey in representative samples of individuals aged 15-24 years in Belgium, Czech and Slovak Republics, France, Italy, Poland and Spain (n = 10 521), identified by a quota sampling method based on age, geographic location and socio-professional category. RESULTS: The overall adjusted prevalence of self-reported acne was 57.8% (95% confidence interval 56.9% to 58.7%). The rates per country ranged from 42.2% in Poland to 73.5% in the Czech and Slovak Republics. The prevalence of acne was highest at age 15-17 years and decreased with age. On multivariate analysis, a history of maternal or paternal acne was associated with an increased probability of having acne (odds ratio 3.077, 95% CI 2.743 to 3.451, and 2.700, 95% CI 2.391 to 3.049, respectively; both P < 0.0001), as was the consumption of chocolate (OR 1.276, 95% CI 1.094 to 1.488, for quartile 4 vs. quartile 1). Increasing age (OR 0.728, 95% CI 0.639 to 0.830 for age 21-24 years vs. 15-17 years) and smoking tobacco (OR 0.705, 95% CI 0.616 to 0.807) were associated with a reduced probability of acne. CONCLUSION: The overall prevalence of self-reported acne was high in adolescents/young adults in the European countries investigated. Heredity was the main risk factor for developing acne.
Asunto(s)
Acné Vulgar/epidemiología , Estilo de Vida , Acné Vulgar/genética , Adolescente , Factores de Edad , Chocolate , Estudios Transversales , Dieta , Europa (Continente)/epidemiología , Femenino , Encuestas Epidemiológicas , Humanos , Masculino , Prevalencia , Factores Protectores , Factores de Riesgo , Autoinforme , Fumar Tabaco , Adulto JovenRESUMEN
BACKGROUND: Acne is common among young people. OBJECTIVE: To describe the burden, management and sources of advice of acne in a representative sample of young people in Europe. METHODS: This cross-sectional survey was conducted in a representative sample of individuals aged 15-24 years from Belgium, Czech and Slovak Republics, France, Italy, Poland and Spain (n = 3099). RESULTS: Most individuals considered their acne (all severity stages) to be no/minor problem, although 29.7% considered it a major problem/burden. Over-the-counter (OTC) topical treatments were used more frequently than prescribed treatments. Acne was diagnosed by physicians in 47.6% of cases; other health professionals (nurses, pharmacists) or patients accounted for the remainder of diagnoses. Physicians were the source of acne information in just over one-quarter of cases (27.0%). The vast majority of advice was from friends/family and the Internet. CONCLUSION: Almost one-third of young people consider acne to be a major problem/burden. Fewer than half of acne diagnoses are made by a physician, and acne is often self-managed using OTC treatments.
Asunto(s)
Acné Vulgar/epidemiología , Acné Vulgar/psicología , Conocimientos, Actitudes y Práctica en Salud , Percepción , Acné Vulgar/diagnóstico , Acné Vulgar/tratamiento farmacológico , Adolescente , Adulto , Estudios Transversales , Europa (Continente)/epidemiología , Familia , Amigos , Humanos , Internet , Medicamentos sin Prescripción/uso terapéutico , Educación del Paciente como Asunto/métodos , Medicamentos bajo Prescripción/uso terapéutico , Prevalencia , Automedicación , Encuestas y Cuestionarios , Adulto JovenRESUMEN
Within their first days of life, newborns' skin undergoes various adaptation processes needed to accommodate the transition from the wet uterine environment to the dry atmosphere. The skin of newborns and infants is considered as a physiological fragile skin, a skin with lower resistance to aggressions. Fragile skin is divided into four categories up to its origin: physiological fragile skin (age, location), pathological fragile skin (acute and chronic), circumstantial fragile skin (due to environmental extrinsic factors or intrinsic factors such as stress) and iatrogenic fragile skin. Extensive research of the past 10 years have proven evidence that at birth albeit showing a nearly perfect appearance, newborn skin is structurally and functionally immature compared to adult skin undergoing a physiological maturation process after birth at least throughout the first year of life. This article is an overview of all known data about fragility of epidermis in 'fragile populations': newborns, children and adolescents. It includes the recent pathological, pathophysiological and clinical data about fragility of epidermis in various dermatological diseases, such as atopic dermatitis, acne, rosacea, contact dermatitis, irritative dermatitis and focus on UV protection.
Asunto(s)
Epidermis/fisiología , Adaptación Fisiológica , Adolescente , Células Cultivadas , Niño , Células Epidérmicas , Humanos , Recién Nacido , Queratinocitos/citologíaRESUMEN
The skin is the largest organ of the body, providing a protective barrier against bacteria, chemicals and physical insults while maintaining homeostasis in the internal environment. Such a barrier function the skin ensures protection against excessive water loss. The skin's immune defence consists of several facets, including immediate, non-specific mechanisms (innate immunity) and delayed, stimulus-specific responses (adaptive immunity), which contribute to fending off a wide range of potentially invasive microorganisms. This article is an overview of all known data about 'fragile skin'. Fragile skin is defined as skin with lower resistance to aggressions. Fragile skin can be classified into four categories up to its origin: physiological fragile skin (age, location), pathological fragile skin (acute and chronic), circumstantial fragile skin (due to environmental extrinsic factors or intrinsic factors such as stress) and iatrogenic fragile skin. This article includes the epidemiologic data, pathologic description of fragile skin with pathophysiological bases (mechanical and immunological role of skin barrier) and clinical description of fragile skin in atopic dermatitis, in acne, in rosacea, in psoriasis, in contact dermatitis and other dermatologic pathologies. This article includes also clinical cases and differential diagnosis of fragile skin (reactive skin) in face in adult population. In conclusion, fragile skin is very frequent worldwide and its prevalence varies between 25% and 52% in Caucasian, African and Asian population.
Asunto(s)
Epidermis/patología , Epidermis/fisiología , Enfermedades de la Piel/patología , Enfermedades de la Piel/fisiopatología , Acné Vulgar/patología , Acné Vulgar/fisiopatología , Acné Vulgar/terapia , Avena , Dermatitis Atópica/patología , Dermatitis Atópica/fisiopatología , Dermatitis Atópica/terapia , Dermatitis por Contacto/patología , Dermatitis por Contacto/fisiopatología , Dermatitis por Contacto/terapia , Eccema/patología , Eccema/fisiopatología , Eccema/terapia , Emolientes/farmacología , Emolientes/uso terapéutico , Epidermis/efectos de los fármacos , Epidermis/inmunología , Epidermis/fisiopatología , Epidermólisis Ampollosa/patología , Epidermólisis Ampollosa/fisiopatología , Epidermólisis Ampollosa/terapia , Humanos , Fitoterapia , Extractos Vegetales/uso terapéutico , Psoriasis/patología , Psoriasis/fisiopatología , Psoriasis/terapia , Retinoides/farmacología , Retinoides/uso terapéutico , Enfermedades de la Piel/inmunología , Enfermedades de la Piel/terapiaRESUMEN
OBJECTIVE AND IMPORTANCE: Physicians are likely to encounter patients with penis disorders and can be caught off guard by these uncommon pathologies, especially because they occur in a sensitive anatomical location. CLINICAL PRESENTATION: Here, we report the case of a patient presenting with benign transient lymphangiectasis of the penis (BTLP), including its differential diagnosis and treatment. Conclusion headings: BTLP is not an uncommon pathology and diagnosis is based only on medical history and clinical examination. The differentiation between Mondor's disease and BTLP is not necessary for treatment.
Asunto(s)
Linfangiectasia/diagnóstico , Enfermedades del Pene/diagnóstico , Diagnóstico Diferencial , Humanos , Linfangiectasia/etiología , Linfangiectasia/terapia , Masculino , Persona de Mediana Edad , Enfermedades del Pene/etiología , Enfermedades del Pene/terapiaRESUMEN
CONTEXT AND AIM: Psoriasis is an immune-mediated skin disorder frequently associated with obesity and type 2 diabetes (T2D). This report is of a clinically significant improvement in psoriasis lesions in a patient with T2D during treatment with a GLP-1 receptor agonist (exenatide). OBSERVATION: A 61-year-old male patient (BMI: 25.5 kg/m(2)) with T2D treated with metformin and sulphonylureas had also complained, since 1980, of extensive psoriasis that required multiple steroid-based treatments [Psoriasis Area and Sensitivity Index (PASI) score: 11]. In September 2008, his diabetes treatment was intensified with exenatide (Byetta(®)) to improve poor glycaemic control. The patient, as expected, lost weight and reduced HbA(1c) levels from 65 mmol/mol to 56 mmol/mol. However, after just 1 month of treatment with exenatide, the patient also reported a dramatic improvement in psoriatic plaques that was confirmed at the 1-year follow-up (PASI: estimated at 3-4). Withdrawal of exenatide was associated with weight gain, deterioration of glycaemic control and deterioration of psoriasis (PASI:>10). After reinstating exenatide treatment, the patient again reported a prompt improvement in psoriasis (PASI: 3.1). CONCLUSION: There was a major and rapid improvement in psoriasis in our patient with T2D following treatment with exenatide. A possible mechanism might be through direct modulation of the immune system by GLP-1 receptor agonists.
Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hipoglucemiantes/uso terapéutico , Células T Asesinas Naturales/metabolismo , Péptidos/uso terapéutico , Psoriasis/tratamiento farmacológico , Receptores de Glucagón/agonistas , Ponzoñas/uso terapéutico , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/inmunología , Relación Dosis-Respuesta a Droga , Exenatida , Receptor del Péptido 1 Similar al Glucagón , Hemoglobina Glucada/metabolismo , Humanos , Hipoglucemiantes/farmacología , Masculino , Persona de Mediana Edad , Células T Asesinas Naturales/efectos de los fármacos , Células T Asesinas Naturales/inmunología , Péptidos/farmacología , Psoriasis/sangre , Psoriasis/inmunología , Resultado del Tratamiento , Ponzoñas/farmacologíaRESUMEN
Patch testing may be desirable or even essential for cases of suspected allergic contact dermatitis. Such testing allows identification with absolute certainty of the causative agent in "supposed" allergic contact dermatitis.
Asunto(s)
Dermatitis Alérgica por Contacto/diagnóstico , Pruebas del Parche , Dermatitis Alérgica por Contacto/clasificación , Dermatitis Alérgica por Contacto/etiología , HumanosRESUMEN
Corticosteroids, which are potent anti-inflammatory and immunomodulator agents used in the treatment of various inflammatory diseases including allergic diseases, can in some cases produce immediate or delayed hypersensitivity reactions. This review summarizes the epidemiological and clinical characteristics of such reactions, including related diagnostic issues. It also presents a detailed analysis of the proposed immunological mechanisms including underlying cross-reactions.
Asunto(s)
Corticoesteroides/inmunología , Antialérgicos/inmunología , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/inmunología , Corticoesteroides/química , Corticoesteroides/uso terapéutico , Antialérgicos/química , Antialérgicos/uso terapéutico , Reacciones Cruzadas/inmunología , Hipersensibilidad a las Drogas/tratamiento farmacológico , Humanos , Piel/inmunología , Piel/patologíaRESUMEN
We report the case of a 29-year-old man with a 14-year history of type 1 diabetes, normal renal function, and mild diabetic retinopathy. The patient progressively developed a generalized allergic reaction to two insulin excipients--protamine and metacresol--with systemic manifestations of tremor, tachycardia, vertigo, shortness of breath, and short episodes of unconsciousness causing him to be out of work. In June 2003, he received a vascularized cadaveric pancreas transplant using induction with polyclonal antibodies along with tacrolimus and sirolimus but without steroids. A hyperglycemic episode following corticosteroid therapy for rejection treatment required reintroduction of insulin therapy with prompt reappearance of allergic manifestations. Now, the patient is euglycemic without insulin or allergic manifestations and a glycated hemoglobin of 6.4%.
Asunto(s)
Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/cirugía , Hipersensibilidad a las Drogas , Insulina/efectos adversos , Adulto , Humanos , Masculino , Trasplante de Páncreas , Resultado del TratamientoRESUMEN
In most cases, contact urticaria is acute and is diagnosed straightforward; indeed it appears immediately after the application of the urticariogen(s) and disappears promptly after removal of the contact. On some rare occasions, contact urticaria is chronic for two main reasons: sometimes, it is provoked by an unknown urticariogen; in other cases, it is one of the clinical signs of protein contact dermatitis. In both situations, diagnostic procedures to be applied are of prime importance; treatment is submitted to the elimination of the responsible urticariogen. Acute and chronic varieties of contact urticaria can be subdivided into two categories: immunological and non-immunological. Diagnostic procedures include prick testing and/or patch testing (with immediate reading).
Asunto(s)
Dermatitis por Contacto/etiología , Urticaria/etiología , Alérgenos/efectos adversos , Animales , Enfermedad Crónica , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Alérgica por Contacto/inmunología , Dermatitis Alérgica por Contacto/fisiopatología , Dermatitis por Contacto/diagnóstico , Dermatitis por Contacto/fisiopatología , Erupciones por Medicamentos/etiología , Humanos , Pruebas Cutáneas , Urticaria/diagnóstico , Urticaria/inmunología , Urticaria/fisiopatología , Xenobióticos/efectos adversosAsunto(s)
Grupo Borrelia Burgdorferi/aislamiento & purificación , Enfermedades de la Mama/microbiología , Enfermedad de Lyme/complicaciones , Reacción en Cadena de la Polimerasa/métodos , Seudolinfoma/microbiología , Enfermedades de la Mama/complicaciones , ADN/análisis , Humanos , Masculino , Persona de Mediana Edad , Pezones/microbiología , Seudolinfoma/complicacionesRESUMEN
Over a period of 19 months, 33 cases of acute allergic contact dermatitis from Veet epilating waxes and/or the accompanying tissue (Reckitt Benckiser, Massy, France) were observed in France and Belgium. The lesions started on the legs and spread to other parts of the body, especially the face, and were sometimes so severe that hospitalization and/or systemic corticosteroids were required. Primary sensitization occurred as early as after the first application in several patients. Patch tests were performed in 26 of the patients and produced strong positive reactions to the tissue (25 times) and/or the wax (13 times). The allergenic culprits in the wax were modified-colophonium derivatives (colophonium in the standard series testing negatively in all except 4 patients), while methoxy PEG-22/dodecyl glycol copolymer and to a lesser degree lauryl alcohol turned out to be the main causal allergens in the tissue.
Asunto(s)
Cosméticos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Adolescente , Adulto , Alérgenos/farmacología , Estudios de Cohortes , Dermatitis Alérgica por Contacto/epidemiología , Femenino , Estudios de Seguimiento , Francia/epidemiología , Remoción del Cabello/efectos adversos , Humanos , Incidencia , Pruebas del Parche , Factores de Riesgo , Ceras/efectos adversosRESUMEN
INTRODUCTION: Hodgkin's lymphoma is rarely evidenced by dermatological signs or symptoms. OBSERVATION: A 37 year-old man progressively developed widespread cutaneous roughness, with small parallel lines producing fish-like scales. A skin biopsy confirmed the diagnosis of acquired ichthyosis, as evidenced by the absence of the epidermal granular layer. The patient's condition was assessed to be satisfactory. However, two months later, his general condition had gradually deteriorated (night sweats, weight loss, axillary and scalp alopecia, and adenopathies). Hodgkin's lymphoma was diagnosed. After treatment with adriamycin, bleomycin, vincristine and dacarbazine, complete remission of the lymphoma was obtained, and concomitantly, the symptoms of acquired ichthyosis resolved; this was confirmed by serial skin biopsies that evidenced the progressive complete restoration of the granular layer. The level of plasmatic vitamin A and carotene, which had decreased before the treatment, returned to normal values. A subsequent relapse of Hodgkin's lymphoma was preceded by the recurrence of ichthyosis; this time vitamin A and carotene levels were not decreased. DISCUSSION: As a paraneoplastic syndrome, acquired ichthyosis as a first sign of Hodgkin's lymphoma is discussed. In the presence of acquired ichthyosis, repeated monitoring of the patient is required since clinical symptoms of Hodgkin lymphoma are often delayed. Acquired ichthyosis is also an early marker of lymphoma recurrence.
Asunto(s)
Enfermedad de Hodgkin/diagnóstico , Ictiosis/etiología , Adulto , Enfermedad de Hodgkin/complicaciones , Enfermedad de Hodgkin/tratamiento farmacológico , Humanos , Ictiosis/tratamiento farmacológico , Masculino , RecurrenciaRESUMEN
BACKGROUND: Porocarcinoma is a malignant tumour of the eccrine sweat duct, arising from acrosyringium. The tumoral lesions involve the deep dermal tissue. CASE REPORT: We report the case of an 84 year-old woman, suffering from a porocarcinoma, extensively involving the major part of the left lower limb. The first symptoms appeared two years ago. Hundreds of metastatic papules and small nodules were present, isolated or confluent into large plaques. The clinical picture was very close to lymphangioma. Diagnosis was confirmed by histopathologic examination. Radiotherapy was useful short-term, allowing partial flattening of the lesions and improving lymphatic drainage, thus providing comfort for the patient. It did not prevent a later progression of the tumoral process. DISCUSSION: Porocarcinoma is a rare tumour that usually appears as a single nodule or a plaque, arising from a preexistent eccrine poroma, or developing de novo. Two histopathological variants are described: trabecular or epidermotropic. This latter form, observed in the present case, is more aggressive, leading to frequent local recurrences and/or metastases. Our report is exceptional: the literature shows only one other case with such widespread cutaneous involvement. The clinical course of our case is discussed.